Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Project ADHERE: TFV Aptamer Biosensor for Adherence
NCT04870671Phase 1Completed
- Sponsor
- Eastern Virginia Medical School
- Start
- Mar 2021
- Primary completion
- Jan 2023
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial (2 arms), sponsored by Eastern Virginia Medical School. Primary endpoint: Tenofovir Levels in Plasma at 14 days. Started Mar 2021; status: completed.
Beyond the preview
Go deeper on NCT04870671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04870671.